Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

What key factors are powering the surge in the hepatitis c market right now?

The size of the hepatitis C market has experienced swift expansion in the recent past. It is projected to rise from $67.17 billion in 2024 to reach $76.32 billion by 2025, presenting a compound annual growth rate (CAGR) of 13.6%. The increase during the historic timeframe is associated with factors such as blood transfusion procedures, usage of injected drugs, insufficient treatment alternatives, and the emergence of direct-acting antivirals (DaaS).

How fast Is the hepatitis c market expected to grow, and what’s its future value?

Anticipated brisk expansion in the hepatitis C market size is evident in the forthcoming years. The market is set to surge to $134.03 billion by 2029, showcasing a compound annual growth rate (CAGR) of 15.1%. Factors propelling this growth can be pinpointed to global eradication endeavors, enhanced testing and screening protocols, increased expenditure on healthcare, telemedicine integration, and the rise of new therapeutic combinations. In the predicted period, key trends comprise accessible and affordable therapy, concentration on high-risk demographics, ameliorated drug formulations, combined efforts and cooperation, along with the inclusion of telehealth and digital-based solutions.

Get your hepatitis c market report here!

https://www.thebusinessresearchcompany.com/report/hepatitis-c-global-market-report

What are the leading drivers of growth in the hepatitis c market?

The hepatitis C market is expected to witness accelerated growth as a result of a rise in viral infections. These infections are initiated by viruses within the body. The treatment for hepatitis C reduces this infection by eliminating it and re-establishing the immune response once the virus is cleared in hepatitis C patients. For example, in August 2024, the Centers for Disease Control and Prevention, a public health agency in the US, reported a rise in the presence of Parvovirus B19, a seasonal respiratory viral infection. The infection rate in individuals across all age groups jumped from 3% in 2022–2024 to 10% in June 2024. The highest increase was observed in children aged between 5–9 years. In this age group, the prevalence leaped from 15% in 2022–2024 to 40% by June 2024. Additionally, there was a significant rise in the percentage of combined samples carrying parvovirus B19 DNA levels, from 1.5% in December 2023 to 19.9% in June 2024. Hence, the hepatitis C market’s growth is predominantly driven by the surge in viral infections.

What are the key segments defining the hepatitis c market?

The hepatitis C market covered in this report is segmented –

1) By Type: Chronic Hepatitis C, Acute Hepatitis C, Other Types

2) By Treatment: Antiviral Drugs, Vaccine, Immune Modulator Drugs, Surgery, Other Treatments

3) By Diagnosis: Liver Biopsy, Blood Tests, Imaging Tests, Other Diagnosis

4) By Distribution Channel: Hospital And Retail Pharmacies, Online Pharmacies

5) By End-User: Hospitals, Clinics, Ambulatory Surgical Centers, Diagnostic Laboratories, Research Institutes, Home Care Settings

Subsegments:

1) By Chronic Hepatitis C: Genotype 1, Genotype 2, Genotype 3, Genotype 4, Genotype 5, Genotype 6

2) By Acute Hepatitis C: Symptomatic, Asymptomatic

3) By Other Types: Mixed Infections, Superinfection

Get your free sample now – explore exclusive market insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=12582&type=smp

Who are the key players steering the development of the hepatitis c market?

Major companies operating in the hepatitis C market include Pfizer Inc., Johnson & Johnson Services Inc., F. Hoffman La Roche Ltd., Merck & Co. Inc., AbbVie Inc., Bayer AG, Novartis AG, Bristol-Myers Squibb Company, Sumitomo Corporation, GlaxoSmithKline plc, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Boehringer Ingelheim International GmbH., Amgen Inc., Toray Industries Inc., Mylan N.V., Teva Pharmaceutical Industries Ltd., Daiichi Sankyo Company Limited, Eisai Co. Ltd., Otsuka Pharmaceutical Co. Ltd., Aurobindo Pharma Ltd., Cipla Ltd., Lupin Limited, Cadila Healthcare Ltd., Biocon Limited

What emerging trends are influencing the growth of the hepatitis c market?

Emerging diagnostic technologies for hepatitis C are becoming a prevalent trend in the hepatitis C market. Major companies involved in this market are leveraging these technologies to maintain their market standings. For instance, in July 2022, F. Hoffmann-La Roche Ltd., a Swiss-based pharmaceutical and diagnostics firm, introduced the Elecsys HCV Duo immunoassay to countries that recognize the CE Mark. The hepatitis C virus (HCV) antigen and antibody status can now be independently and simultaneously evaluated from a single human plasma or serum sample thanks to the Elecsys HCV Duo immunoassay. This test can identify patients who are either recovering or show symptoms of chronic infection that might lead to other conditions like liver cancer and early-stage illnesses.

Unlock exclusive market insights – purchase your research report now for a swift delivery!

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12582

Which regions are most influential in expanding the hepatitis c market?

North America was the largest region in the hepatitis C market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the hepatitis C market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Browse Through More Similar Reports By The Business Research Company:

Antivirals Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/antivirals-global-market-report

Hepatitis Drugs Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/hepatitis-drugs-global-market-report

Hepatitis Therapeutics Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/hepatitis-therapeutics-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at [email protected]

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: